LSD1-targeted therapy-a multi-purpose key to unlock immunotherapy in small cell lung cancer
Transl Lung Cancer Res
.
2023 Jun 30;12(6):1350-1354.
doi: 10.21037/tlcr-23-40.
Epub 2023 Mar 30.
Authors
Martin Sattler
1
2
,
Ravi Salgia
3
Affiliations
1
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
2
Department of Medicine, Harvard Medical School, Boston, MA, USA.
3
Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA.
PMID:
37425423
PMCID:
PMC10326781
DOI:
10.21037/tlcr-23-40
No abstract available
Keywords:
LSD1; Small cell lung cancer (SCLC); epigenetics; immune checkpoint blockade.
Publication types
Editorial
Comment